Dynavax Technologies Corp. (DVAX), a vaccine maker, announced on Monday that it has entered into an accelerated share repurchase or ASR under a deal with Goldman Sachs & Co. LLC to repurchase $100 million of shares. The company has executed the ASR as part of the $200 million share repurchase authorized by its Board in November. Upon completion of this ASR, Dynavax will have $100 million remaining under the program.
The final settlement of the ASR is expected to be completed in the first quarter of 2025. As of November 5, Dynavax had around 131.5 million shares outstanding.
For comments and feedback contact: editorial@rttnews.com
Business News
June 19, 2026 16:46 ET Major central banks continued to dominate the economic news flow this week too, led by the Federal Reserve, as they announced their latest policy decisions. The Federal Reserve policy session was in focus as it was the first to be led by the new chief Kevin Warsh. In Europe, central banks of the U.K. and Switzerland announced their rate decisions. In Asia, the Bank of Japan drew attention for its policy moves, while data out of China threw some light on the state of the economy.